Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

globenewswire.com
MLYS The article announces the company's participation in a conference, which is a standard corporate event. No specific financial or product news is shared that would indicate a strong bullish or bearish sentiment.

Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference RADNOR, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced that management will be participating in the Bank of America Securities 2026 Health Care Conference being held in Las Vegas on May 11-14, 2026.

A live webcast of this fireside chat can also be accessed on the “ News & Events” page in the Investor Relations section of the Mineralys Therapeutics website.

About Mineralys Therapeutics

Mineralys Therapeutics is a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as CKD, OSA and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky.

Contact:

Investor Relations

investorrelations@mineralystx.com

Media Relations

Melyssa Weible

Elixir Health Public Relations

Email: mweible@elixirhealthpr.com